1. | Ozato K, Mayer NM, Sachs DH. Monoclonal antibodies to mouse major histocompatibility complex antigens. IV. A series of hybridoma clones producing anti-H-2d antibodies and an examination of expression of H-2d antigens on the surface of these cells. Transplantation. 1982;34:113-9. (Immunogen, CMDC) | 2. | Kane KP. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med. 1994;179:1011-5. (Block, Purification, Adhesion) | 3. | Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F. Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J Exp Med. 1996;183:1553-9. (Block, Adhesion) | 4. | Beck JC, Hansen TH, Cullen SE, Lee DR. Slower processing, weaker β2-M association, and lower surface expression of H-2Ld are influenced by its amino terminus. J Immunol. 1986;137:916-23. (IP) | 5. | Lie W, Myers NB, Connolly JM, Gorka J, Lee DR, Hansen TH. The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure. J Exp Med. 1991;173:449-59. (IP) | 6. | White J, Crawford F, Fremont D, Marrack P, Kappler J. Soluble class I MHC with β2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma. J Immunol. 1999;162:2671-6. (Purification, ELISA) | 7. | Mage MG, Lee Li, Ribaudo RK, Corr M, Kozlowski S, McHugh L, et al. A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity. Proc Natl Acad Sci USA. 1992;89:10658-62. (ELISA) | 8. | Paquet M, Cohen-Doyle M, Shore GC, Williams DB. Bap29/31 influences the intracellular traffic of MHC class I molecules. J Immunol. 2004;172:7548-55. (IP, ICC, FC) |
|